Carlsmed Raises $52.5M Series C - San Diego Business Journal sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.
Carlsmed Raises $10M to Commercialize Breakthrough aprevo™ Devices Today, Carlsmed, Inc. announces the close of a $10M Series A financing to commercialize the
aprevo family of spine deformity correction devices. The San Diego-based medical device company is focused on improving outcomes for patients with adult spinal deformity. Carlsmed has pioneered a novel digital + surgical solution to create optimized surgical plans and personalized
aprevo implants to enable superior correction of the spinal deformity. This round of financing is led by U.S. Venture Partners (USVP) and includes participation from The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others. This round of financing comes at the perfect time to meet surgeon and patient demand for the newly launched Breakthrough
Carlsmed, Inc., a San Diego, CA-based medical device company, closed a $10M Series A financing round.
The round was led by U.S. Venture Partners with participation from The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others.
The company intends to use the funds to commercialize its devices.
Led by Mike Cordonnier, CEO, Carlsmed is the maker of the
aprevo family of spine deformity correction devices. Its novel digital + surgical solution creates optimized surgical plans and personalized implants to enable superior correction of the spinal deformity.
In conjunction with the Series A closing, the company announced the appointment of three directors to the board, Jonathan Root, M.D., Phil Young, and Kevin Sidow.
Daily Business Report-Dec. 17, 2020, San Diego Metro Magazine sandiegometro.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegometro.com Daily Mail and Mail on Sunday newspapers.